Five Questions on Innovation, Health IT, and Biotech for Lux Capital’s New Venture Partner Richard Foster

in incentives for companies to provide services and products. But this will be a long road. Also the Department of Health & Human Services is releasing tremendous amounts of data.

On June 9, HHS will be holding a national meeting on health data initiatives. There will be dozens of younger companies there talking about their plans to use this resource.

X: One of your mandates, according to Lux, is to seek out new business models for life sciences. Explain.

RF: Our system of drug development, in the eyes of many, is broken. Researchers at academic medical centers are focusing on discovering what’s going wrong in the diseased body. Drug companies are trying to figure out how to fix it. But the interface between the two isn’t working. And no one is answering the question of who is going to bear the cost of further development. This system cannot continue as it is currently structured.

You’ll see a lot of private funds looking at new ways to do drug development. We’ll be looking at those new models, too.

X: How will your challenge differ from that of Lux’s other new partner, James Woolsey?

RF: The capital requirements for energy and climate are so much greater than they are for healthcare, which makes them very different issues. But we have to solve energy and climate problems, and we will. It’s a wonderful part of the equation for Lux, and I’m happy to be working with James Woolsey.

X: Having written two books about innovation, what’s your top advice for new entrepreneurs?

RF: They need to avoid what I call “cultural lock-in”—the tendency to build a business model and then not be able to see any other model from then on. You have to think of the next wave of entrepreneurs that are behind you, and you have to know exactly how you’re going to beat them.

I once met Bob Swanson, the original CEO of Genentech. I told him he was the perfect example of an attacker, but he said he didn’t think of himself that way. He said, “I’m worried about these guys who are behind me.” That’s the attitude entrepreneurs need to have—the Swanson attitude.

Remember, the world doesn’t stop just because you started a company.

Author: Arlene Weintraub

Arlene is an award-winning journalist specializing in life sciences and technology. She was previously a senior health writer based out of the New York City headquarters of BusinessWeek, where she wrote hundreds of articles that explored both the science and business of health. Her freelance pieces have been published in USA Today, US News & World Report, Technology Review, and other media outlets. Arlene has won awards from the New York Press Club, the Association of Health Care Journalists, the Foundation for Biomedical Research, and the American Society of Business Publication Editors. Her book about the anti-aging industry, Selling the Fountain of Youth, was published by Basic Books in September 2010.